Oxidized LDL Enhances Pro-inflammatory Responses of Alternatively Activated M2 Macrophages: a Crucial Role for Krüppel-like Factor 2
Overview
Affiliations
Objective: Macrophages are key players in atherogenesis because of their properties to form foam cells that produce a large variety of pro-inflammatory mediators. We addressed the potency of phenotypic different macrophages to accumulate oxidized LDL.
Methods And Results: Surprisingly, anti-inflammatory M2 macrophages but not pro-inflammatory M1 macrophages rapidly accumulated oxidized LDL. Simultaneously, expression of Krüppel-like factor 2, a nuclear transcription factor known to suppress inflammation in endothelial cells and monocytes, decreased and the functional phenotype of M2 macrophages shifted towards a pro-inflammatory profile, characterized by higher production of IL-6, IL-8 and MCP-1 and lower expression of IL-10 upon stimulation with LPS. In contrast, Krüppel-like factor 2 expression and the phenotype of M1 macrophages remained largely unchanged upon oxidized LDL exposure. Downregulation of Krüppel-like factor 2 expression of M2 macrophages using siRNA technology led to a significant increase of LPS-induced MCP-1 secretion.
Conclusions: We show that (1) anti-inflammatory M2 macrophages are more susceptible to foam cell formation than pro-inflammatory M1 macrophages, (2) exposure to oxidized LDL renders M2 macrophages pro-inflammatory, and (3) Krüppel-like factor 2 is involved in the enhanced secretion of MCP-1 by M2 macrophages loaded with oxidized LDL. The phenotype switch of M2 macrophages from an anti- to a pro-inflammatory profile may play an important role in pathogenesis of atherosclerosis, and could represent a novel therapeutic target.
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.
Extracellular Vesicles as Mediators of Endothelial Dysfunction in Cardiovascular Diseases.
Jimenez-Trinidad F, Calvo-Gomez S, Sabate M, Brugaletta S, Campuzano V, Egea G Int J Mol Sci. 2025; 26(3).
PMID: 39940780 PMC: 11816526. DOI: 10.3390/ijms26031008.
Andersen C, Fernandez M Nutrients. 2025; 17(1.
PMID: 39796476 PMC: 11722654. DOI: 10.3390/nu17010042.
Hao K, Wang J, Niu Y, Wang F J Orthop Surg Res. 2024; 19(1):845.
PMID: 39696586 PMC: 11657670. DOI: 10.1186/s13018-024-05326-2.
Immune Implications of Cholesterol-Containing Lipid Nanoparticles.
Back P, Yu M, Modaresahmadi S, Hajimirzaei S, Zhang Q, Islam M ACS Nano. 2024; 18(42):28480-28501.
PMID: 39388645 PMC: 11505898. DOI: 10.1021/acsnano.4c06369.